Glenn Reicin - 14 Apr 2026 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: HRMY
Reported as of: 14 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2026, 16:13:05 UTC
Source filing: View source filing
Reporting owner signature: /s/ Christian Ulrich, Attorney-in-Fact

Key filing fact

Glenn Reicin filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 18 May 2026.

Key facts

This page summarizes Glenn Reicin's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 May 2026, 16:13.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001790218 Primary reporting owner

Reicin Glenn

Relationship: CHIEF FINANCIAL OFFICER
Address: C/O HARMONY BIOSCIENCES HOLDINGS, INC., PLYMOUTH MEETING
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Signature date: 18 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRMY transaction Derivative

Stock Option

Award

Transaction value
Shares: +164,309
Change %
Price: $0.000000^*
Shares after: 164,309
Date: 14 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 164,309
Exercise price: $29.29
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests with respect to 25% of the underlying shares on April 14, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.